AZCC | BSS HOME | SERVICES | PUBLICATIONS | DIRECTORY | CONTACT US

Representative Publications

April 2004 - January 2006

2006

  • Baker AF, Dragovich T, Tate WR, Ramanathan RK, Roe D, Hsu CH, Kirkpatrick DL, Powis G: The antitumor thioredoxin-1 inhibitor PX-12 decreases thioredoxin-1 and VEGF levels in cancer patient plasma. J Lab Clin Med 147: 83-90, 2006.

 

  • Correlation of P53 expression and 14-3-3 expression, Haiyan Cui, January 2006.

 

  • Effect of Paclitaxel, Triacetin and ultrasound on tumor growth, Sylvia Brown, January 2006.

 

  • Effect of Bleomycin on histology scores in skin, Haiyan Cui, January 2006.

 

  • Gabayan AJ, Green SB, Sanan A, Jenrette J, Schultz C, Papagikos M, et al: GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery 58: 701-709, 2006.

 

  • Kwei KA, Finch JS, Ranger-Moore J, Bowden GT: The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Lett 231: 326-338, 2006.

 

  • Yerushalmi HF, Besselsen DG, Ignatenko NA, Blohm-Mangone KA, Padilla-Torres JL, Stringer DE, Cui H, Holubec H, Payne CM, Gerner EW: The role of NO syntheses in arginine-dependent small intestinal and colonic carcinogenesis. Mol Carcinog 45: 93-105, 2006.

2005

 

  • Alberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P, and the Phoenix & Tucson Gastroenterologist Networks: Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97: 846-853, 2005.

 

  • Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S, Bearss D, Nagle RB: Aurora-A over-expression in high-grade PIN lesions and prostate cancer. The Prostate 64: 341-346, 2005.

 

  • Chen Z, Bassford T, Green SB, Cauley JA, Jackson RD, LaCroix AZ, Leboff M, Stefanick ML, Margolis KL: Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative.  Am J Clin Nutr 82: 651-656, 2005.

 

  • Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, Celaya CA, Rodney SR, Hara Y, Alberts DS:  Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11 :4627-4633, 2005.

 

  • Frank DH, Davis JR, Ranger-Moore J, Liu Y, Bartels HG, Alberts DS, Bartels PH: Karyometry of infiltrating breast lesions. Anal Quant Cytol Histol 27: 195-201, 2005.

 

  • Hsu C-H: Joint modeling of recurrence and progression of adenoma polyps:  A latent variable approach. Statistical Modeling 5:1-15, 2005.

 

  • Hsu, C-H: Joint modeling of recurrence and progression of adenomas: a latent variable approach.  Statistical Modeling 5: 201-215, 2005.

 

  • List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB:  Efficacy of lenalidomide in myelodysplastic syndromes.  New Engl J Med 352:549-557, 2005.

 

  • Morse DL, Carroll D, Weberg L, Borgstrom MC, Ranger-Moore J, Gillies RJ: Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 342: 69-77, 2005.

 

  • Payne CM, Holubec H, Bernstein C, Bernstein H, Dvorak K, Green SB, et al: Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2066-2075, 2005.

 

  • Payne CM, Holubec H, Bernstein C, Bernstein H, Dvorak K, Green SB, et al: Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev 14: 2066-2075, 2005.

 

  • Ranger-Moore J, Alberts DS, Montironi R, Garcia F, Davis J, Frank D, Brewer M, Mariuzzi GM, Bartels HG, Bartels PH:  Karyometry in the early detection and chemoprevention of intraepithelial lesions. Eur J Cancer 41: 1875-1888, 2005.

 

  • Ranger-Moore J, Frank D, Lance P, Alberts D, Yozwiak M, Bartels HG, Einspahr J, Bartels PH: Karyometry in rectal mucosa of patients with previous colorectal adenomas. Anal Quant Cytol Histol 27: 134-142, 2005.

 

  • Summary of DFMO/Triamcinolone Study, Kathy Saboda, December 2005.

 

 
2004

  • Alberts D, Ranger-Moore J, Einspahr J, Saboda K, Bozzo P, Liu Y, Xu X-C, Lotan R, Warneke J, Salasche S, Stratton S, Levine N, Goldman R, Islas M, Duckett L, Thompson D, Bartels P:  Safety and efficacy of dose-intensive oral vitamin A in subjects with sun-damaged skin.  Cl Can Res 10:1875-1880, 2004.

 

  • Chen Z, Stini WA, Marshall JR, Martinez ME, Guillen-Rodriguez JM, Roe D, Alberts DS:  Wheat bran fiber supplementation and bone loss among older people.  Nutrition 20:747-751, 2004.

 

  • Dvorakova K, Payne CM, Ramsey L. Holubec H, Sampliner R, Dominguez J, Dvorak B, Bernstein H, Bernstein C, Prasad A, Fass R, Cui H, Garewal H:  Increased expression and secretion of interleukin-6 in patients with Barrett’s esophagus.  Clin Cancer Res. 10:2020-8, 2004.

 

  • Garcia FA, Ranger-Moore J, Barker B, Davis J, Brewer M, Lozevski J, Vinyak S, Liu Y, Yemane J, Hatch KD, Alberts DS, Bartels HG, Bartels PH: Karyometric image analysis for intraepithelial and invasive cervical lesions. Anal Quant Cytol Histopathol. 26(3):141-50, 2004.

 

  • Hess LM, Krutzsch MF, Guillen J, Chow H-HS, Einspahr J, Batta AK, Salen G, Reid ME, Earnest DL, Alberts DS: Results of a Phase I multiple-dose clinical study of ursodeoxycholic acid. Cancer Epidemiol Biomarkers Prev. 13:861-867, 2004.

 

  • Jacobs ET, Giuliano AR, Roe DJ, Guillen-Rodriquez JM, Hartz VL, Whitacre RC, Alberts DS,  Martinez ME:  Dietary change in an intervention trial of wheat bran fiber and colorectal adenoma recurrence.  Annals of Epidemiology 14:280-286, 2004.

 

  • Ranger-Moore J, Bartels PH, Thompson D, Bozzo P, Einspahr J, Liu Y, Saboda KL, Duckett L, Alberts DS:  Karyometric analysis of actinic damage in unexposed and sun-exposed skin, and in actinic keratoses in untreated individuals. Anal Quant Cytol Histopathol. 26(3):155-65, 2004.

 

  • Staten LK, Gregory-Mercado KY, Ranger-Moore J, Will JC, Giuliano AR, Ford ES, Marshall J: Provider counseling, health education and community health workers: the Arizona WISEWOMAN Project. J Women’s Health 13(5):547-556, 2004.

 

  • Theilmann RJ, Borders R, Trouard TP, Xia G, Outwater E, Ranger-Moore J, Gillies RJ, Stopeck A: Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia  6:831-837, 2004.

 

Webmaster | Privacy Policy | Disclaimer
Arizona Cancer Center :: 1515 North Campbell Ave., Tucson, AZ 85724-5024
Copyright ABOR :: All rights reserved.

PHP Warning: PHP Startup: Unable to load dynamic library './php_gd2.dll' - The specified module could not be found. in Unknown on line 0